The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy comparison of pazopanib and trabectedin vs standard chemotherapy in second line treatment of patients with metastatic soft tissue sarcomas: Experience from countries with limited resources.
 
Anes Pasic
Honoraria - Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Luka Simetic
No Relationships to Disclose
 
Davorin Herceg
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Roche
Research Funding - Roche
Expert Testimony - Merck; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche
 
Timur Ceric
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Novartis; Pfizer; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Elma Kapisazovic
No Relationships to Disclose
 
Semir Beslija
Honoraria - Roche
Consulting or Advisory Role - Merck; MSD; Novartis; Pfizer; Roche
Research Funding - Roche